Article

Anya Prince on Insurance Coverage for Preventative Services

Author(s):

Anya Prince

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.

Related Videos
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Image of man with grey hair.
Image of man with black hair.
Image of doctor with grey hair.
Image of doctor with black hair.
Related Content
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Site Logo
July 23rd 2020

Knowing Your Rights When It Comes to Cancer and Your Career

Ryan McDonald Jessica Skarzynski
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Monica Bryant, chief operating officer of Triage Cancer, about the rights patients with cancer have when it comes to the workplace.
Image of doctor with brown hair.
February 25th 2025

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

Dr. Vaia Florou
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Site Logo
June 25th 2020

Genetic Counseling for Cancer Shifts to a New Era of Virtual Care

Jessica Skarzynski
In this episode of the “CURE Talks Cancer” podcast we interview genetic counselor Dana Farengo Clark on how genetic counseling is adjusting to the new normal and shifting into the virtual era of cancer care.
Dr. Robert Jones is a professor of Clinical Cancer Research at The University of Glasgow School of Cancer Sciences, in Scotland.
February 15th 2025

Bavencio Has Efficacy in The Real-World Treatment of Urothelial Cancer

Dr. Robert Jones
Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for nine months.
Image of man with black hair.
February 3rd 2025

Rybrevant Alone and in Combo With Chemo is Efficacious in Wildtype+ mCRC

Ryan Scott
Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.